secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2026-05-22T20:30:28+00:00
Accession:  0001213900-26-060600
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 4.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne restates Q1 FY2026 results due to revenue recognition error; reaffirms FY2026 guidance
--------------------------------------------------------------------------------

- Revenue overstated by ~$0.5M, net loss understated by ~$0.3M for quarter ended March 31, 2026.
- Restatement caused by customer order modification at quarter-end; no prior periods affected.
- Company reaffirms FY2026 product revenue guidance of at least $10.5M.
- Internal control weakness identified; measures to improve controls are being implemented.
- Audit Committee determined non-reliance on previously filed Form 10-Q for March 31, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390026060600/0001213900-26-060600-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390026060600/ea0291925-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-060600

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer